guizani kaouther (9 risultati)

Paperback. Condizione: Brand New. 84 pages. 6.00x0.19x9.00 inches. In Stock.

PAP. Condizione: New. New Book. Shipped from UK. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

PAP. Condizione: New. New Book. Delivered from our UK warehouse in 4 to 14 business days. THIS BOOK IS PRINTED ON DEMAND. Established seller since 2000.

Condizione: New. Print on Demand.

Condizione: New. Print on Demand.

Condizione: New. PRINT ON DEMAND.

Paperback. Condizione: new. Paperback. Aggressive cancers, such as Inflammatory Breast Cancer (IBC), Glioblastoma (GBM), and Colorectal Cancer (CRC), pose significant treatment challenges due to their rapid progression and high metastatic potential. Current therapies often cause severe side effects, highlighting the need for novel therapeutic strategies. The venom of the Tunisian viper, Macrovipera lebetina, has emerged as a promising source of bioactive molecules with potential anti-cancer properties. This study aimed to isolate and evaluate the anti-tumor effects of Leberagin C, a novel protein derived from M. lebetina venom. Materials and Methods: A bio-guided purification approach was employed to isolate Leberagin C from M. lebetina venom. Its pharmacological effects were evaluated using three cancer cell lines: U251 (glioblastoma), Caco-2 (colorectal cancer), and SUM 149 (inflammatory breast cancer). Functional assays assessed the impact of Leberagin C on cell migration, adhesion, and proliferation. Results: Leberagin C demonstrated significant anti-tumor activity in all tested cell lines. It effectively inhibited cancer cell migration, adhesion, and proliferation, suggesting its potential role in disrupting tumor progression. Conclusion: Leberagin C holds promise as a potential therapeutic agent for aggressive cancers, either as a standalone treatment or in combination with existing therapies. Further studies are needed to explore its mechanism of action and clinical applications. This item is printed on demand. Shipping may be from our UK warehouse or from our Australian or US warehouses, depending on stock availability.

Taschenbuch. Condizione: Neu. nach der Bestellung gedruckt Neuware - Printed after ordering - Aggressive cancers, such as Inflammatory Breast Cancer (IBC), Glioblastoma (GBM), and Colorectal Cancer (CRC), pose significant treatment challenges due to their rapid progression and high metastatic potential. Current therapies often cause severe side effects, highlighting the need for novel therapeutic strategies. The venom of the Tunisian viper, Macrovipera lebetina, has emerged as a promising source of bioactive molecules with potential anti-cancer properties. This study aimed to isolate and evaluate the anti-tumor effects of Leberagin C, a novel protein derived from M. lebetina venom. Materials and Methods: A bio-guided purification approach was employed to isolate Leberagin C from M. lebetina venom. Its pharmacological effects were evaluated using three cancer cell lines: U251 (glioblastoma), Caco-2 (colorectal cancer), and SUM 149 (inflammatory breast cancer). Functional assays assessed the impact of Leberagin C on cell migration, adhesion, and proliferation.Results: Leberagin C demonstrated significant anti-tumor activity in all tested cell lines. It effectively inhibited cancer cell migration, adhesion, and proliferation, suggesting its potential role in disrupting tumor progression.Conclusion: Leberagin C holds promise as a potential therapeutic agent for aggressive cancers, either as a standalone treatment or in combination with existing therapies. Further studies are needed to explore its mechanism of action and clinical applications.

Taschenbuch. Condizione: Neu. Leberagin C from Macrovipera lebetina Venom | A Potential Therapeutic Agent for Aggressive Cancers | Guizani Kaouther | Taschenbuch | Englisch | 2025 | Eliva Press | EAN 9789999327213 | Verantwortliche Person für die EU: Libri GmbH, Europaallee 1, 36244 Bad Hersfeld, gpsr[at]libri[dot]de | Anbieter: preigu Print on Demand.